- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MOBILE-HEALTH NETWORK SOLUTIONS Aktie jetzt für 0€ handeln | |||||
| 26.03. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.03. | Mobile-health Network Solutions files to sell 3.34M Class A ordinary shares | 1 | Seeking Alpha | ||
| 21.03. | Mobile-health Network Solutions - F-1, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 06.03. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 27.02. | Centurion One Capital Corp.: Mobile-health Network Solutions to Present at Centurion One Capital 8th Annual Growth Conference | 239 | Newsfile | Singapore, Singapore--(Newsfile Corp. - February 27, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a pioneering MedTech company dedicated to enhancing human connection... ► Artikel lesen | |
| 19.02. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 04.02. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 17.01. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 26.12.24 | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 17.12.24 | Mobile-health Network Solutions Launches ManaSocial, New Digital Healthcare Engagement Platform Expected to Accelerate Growth | 3 | GlobeNewswire (USA) | ||
| 23.10.24 | Mobile-health Network Solutions Reports 77 Percent Revenue Increase for Fiscal Year 2024 | 258 | GlobeNewswire (Europe) | SINGAPORE, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the fiscal... ► Artikel lesen | |
| 15.10.24 | Mobile-health Network Solutions Announces Participation in the LD Micro Main Event XVII | 259 | Newsfile | Singapore, Singapore--(Newsfile Corp. - October 15, 2024) - Mobile-health Network Solutions (NASDAQ: MNDR), a leading Asia-Pacific telehealth provider, announced today that it will be presenting at... ► Artikel lesen | |
| 21.09.24 | Mobile-health Network Solutions Delinquency Notification Letter From Nasdaq | 336 | GlobeNewswire (Europe) | SINGAPORE, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it received... ► Artikel lesen | |
| 19.06.24 | Mobile-health Network Solutions Pte Ltd: Mobile-health Network Solutions [MaNaDr] to Offer GLP-1 Injectables for Medical Weight Loss from USD10/Day | 544 | JCN Newswire | SINGAPORE, June 19, 2024 - (NewMediaWire) - Mobile-health Network Solutions ['MaNaDr'](Nasdaq: MNDR), a leading Asia-Pacific telehealth provider, today announced updated pricing for its medical weight... ► Artikel lesen | |
| 21.05.24 | Mobile-health Network Solutions Revenue Rises Approximately 120% in the First Six Months of Fiscal 2024 | 297 | GlobeNewswire (Europe) | SINGAPORE, May 21, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the first... ► Artikel lesen | |
| 22.04.24 | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | 305 | GlobeNewswire (Europe) | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,123 | -2,38 % | Sernova Biotherapeutics Inc: Sernova closes $4-million term loan from Navigate | ||
| ATOSSA THERAPEUTICS | 0,540 | -1,46 % | Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer | CAMBRIDGE, Mass., April 10, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM)... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,784 | -0,03 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports First Full-Year Profit in 2024 | Synergies Between Health Care and Insurance Drive Scalable GrowthAI Innovations Fuel Continued Success
SHANGHAI and HONG KONG, March 13, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,011 | -3,39 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,288 | +3,60 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,907 | 0,00 % | CytoSorbents Gains $1.7M Via NJEDA Tax Credit Sale To Fund Strategic Growth | ||
| VERU | 0,460 | -2,38 % | Veru Aktie: Bedeutet das eine Neuausrichtung? | Die Veru-Aktie verliert weiter an Wert, doch Analysten bleiben optimistisch aufgrund vielversprechender Medikamentenentwicklungen. Wird der Tiefpunkt bald erreicht? Die Veru-Aktie setzt ihre Abwärtsspirale... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP | BRISBANE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| VOLITIONRX | 0,483 | 0,00 % | VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Monday, March 31 at 4:30 p.m. U.S. Eastern Time HENDERSON, Nevada, March 31, 2025 /PRNewswire/ -- VolitionRx... ► Artikel lesen | |
| EKSO BIONICS | 0,350 | -2,23 % | Ekso Bionics Holdings Aktie: Beeindruckende Innovationskraft | Der Exoskelett-Hersteller verzeichnet im letzten Quartal 2024 Umsatzsteigerungen und Margenwachstum, kämpft jedoch mit Jahresrückgang bei hoher Aktienvolatilität. Ekso Bionics meldete für das vierte... ► Artikel lesen | |
| IMUNON | 0,750 | +0,67 % | Imunon, Inc.: IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting | ||
| BEYOND AIR | 0,208 | -1,89 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | ||
| AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| NOVACYT | 0,485 | +4,19 % | Novacyt legt Termin für Finanzergebnisse 2024 fest | ||
| AROVELLA THERAPEUTICS | 0,043 | +8,86 % | Arovella tackles CAR-T's limitations in cancer treatment with off-the-shelf innovation |
MOBILE-HEALTH NETWORK SOLUTIONS gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,430 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MOBILE-HEALTH NETWORK SOLUTIONS finden Sie auf Wallstreet Online.
